The system is designed to provide routine high-throughput quantitation to laboratories to clinical laboratories.
Allows interrogation of DNA mutations, RNA fusion transcripts, and gene expression levels associated with myeloid cancers in a single run.
Chromatrap has launched a range of Chromatin Immunoprecipitation (ChIP)-validated antibodies, which are vital to modern epigenetic research
This new PCR Optimization Kit allows customers to rapidly define their own unique PCR master mix.
MDxHealth has launched its AssureMD for Bladder Cancer test in the U.S. as a laboratory developed test (LDT).
The ampDRY hotstart master mix was developed to enable complete end-stage or real-time PCR assay stabilization in a dry format.
The PD-L1 assay and the AccuCyte-CyteFinder system processes a single tube of blood to cells for CTC enumeration and PD-L1 biomarker expression analysis, and to plasma for optional cfDNA analysis.
Biocept's Target Selector test enables physicians to identify the potential presence of NTRK fusions used to inform on treatment options.
The assay now has comprehensive sample type coverage for HSV
Liquid biopsy test provider Biocept has announced Target Selector NGS Breast Panel, a multi-gene liquid biopsy panel specifically developed for breast cancer. The Target...